Scenarios that move LH
Labcorp Holdings Inc. Common Stock
Scenarios that move LH: 10 analyses, 9 positive, 1 negative.
- · OPKO Health to sell BioReference assets to Labcorp for $722M — ▲ · impact +58 · confidence high · horizon quarters
- · FDA expands ImmunityBio's Anktiva label for bladder cancer — ▲ · impact +12 · confidence medium · horizon weeks
- · Mirum's Livmarli meets Phase III goal in ultra-rare liver diseases — ▲ · impact +7 · confidence low · horizon quarters
- · UnitedHealth tops estimates, raises profit outlook despite high medical costs — ▲ · impact +38 · confidence low · horizon quarters
- · argenx meets primary endpoint in Phase II celiac disease study — ▲ · impact +12 · confidence low · horizon quarters
- · Spyre Therapeutics prices $350 million public stock offering — ▲ · impact +12 · confidence low · horizon quarters
- · DBV Technologies files FDA BLA for VIASKIN Peanut patch — ▲ · impact +11 · confidence low · horizon quarters
- · Mirum's Brelovitug meets goal in Phase III AZURE-1 study — ▲ · impact +17 · confidence low · horizon quarters
- · FDA approves Isembyld for spinal muscular atrophy treatment — ▲ · impact +10 · confidence low · horizon quarters
- · Amgen shares fall after Novartis' Pelacarsen misses Phase III goal — ▼ · impact -15 · confidence low · horizon quarters